Actionable news
0
All posts from Actionable news
Actionable news in DVAX: Dynavax Technologies Corporation,

Dynavax Technologies Corporation releases salary data. CEO sees compensation fall -26%

Dynavax Technologies Corporation just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 3,943,607.

The table is included below:

Name and Principal Position

Year Salary Bonus (1) Stock
Awards (2)
Option
Awards (3)
Non-Equity
Incentive Plan
Compensation (4)
All Other
Compensation (5)
Total

Eddie Gray

2015 $ 566,500 $ $ $ 3,004,616 $ 370,491 $ 2,000 $ 3,943,607

CEO and Director

2014 $ 515,000 $ $ 855,000 $ 3,564,909 $ 432,600 $ $ 5,367,509
2013 $ 333,333 $ 200,000 $ $ 3,030,000 $ 50,000 $ 200,250 $ 3,813,583

Michael S. Ostrach

2015 $ 390,000 $ $ $ 1,420,353 $ 228,150 $ 2,000 $ 2,040,503

Senior Vice President, Chief
Financial Officer and Chief
Business Officer

2014 $ 354,152 $ $ 181,000 $ 425,331 $ 221,345 $ $ 1,181,828
2013 $ 342,176 $ $ $ 561,960 $ 185,000 $ 3,616 $ 1,092,752

Robert L. Coffman, Ph.D.

2015 $ 453,200 $ $ $ 1,300,631 $ 253,792 $ 2,000 $ 2,009,623

Senior Vice President and
Chief Scientific Officer

2014 $ 440,000 $ $ 42,250 $ $ 286,000 $ $ 768,250
2013 $ 282,620 $ $ $ 505,764 $ 175,000 $ 250 $ 963,634

Robert Janssen, M.D.

2015 $ 369,513 $ $ $ 747,816 $ 206,928 $ 2,000 $ 1,326,257

Chief Medical Officer and
Vice President, Clinical
Development

2014 $ 358,750 $ $ 181,000 $ 283,554 $ 246,641 $ $ 1,069,945
2013 $ 323,878 $ $ 175,500 $ $ 145,000 $ 4,361 $ 648,739

David F. Novack

2015 $ 375,000 $ $ $ 1,001,539 $ 210,000 $ 2,000 $ 1,588,539

Senior Vice President,
Operations and Quality

2014 $ 309,000 $ $ 362,000 $ 346,566 $ 208,575 $ $ 1,226,141
2013 $ 230,769 $ 75,000 $ $ 587,100 $ 155,000 $ 1,932 $ 1,049,801

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Dynavax Technologies Corporation makes a similar move, sign up!

Other recent filings from the company include the following:

Dynavax Technologies: 2929 Seventh Street, Suite 100 - March 31, 2016